Regulation of ocular angiogenesis by microRNAs

microRNA对眼部血管生成的调节

• 批准号: 8725162
• 负责人: Shusheng Wang
• 金额: $ 36.87万
• 依托单位: TULANE UNIVERSITY OF LOUISIANA
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-01 至 2016-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8725162
• 关键词: Age related macular degeneration; Angiogenic Factor; Blood Vessels; Choroid; Choroidal Neovascularization; Data; Development; Diabetic Retinopathy; Disease; Endothelial Cells; Endothelium; Exudative age-related macular degeneration; Eye Development; Fibroblast Growth Factor; Future; Gene Expression; Gene Targeting; Genetic; Goals; Lasers; MAP Kinase Gene; MicroRNAs; Mitogen-Activated Protein Kinases; Modeling; Outcome; Pathogenesis; Pathologic Neovascularization; Pathway interactions; Pattern; Play; Proto-Oncogene Proteins c-akt; Regulation; Retina; Retinal; Retinal Diseases; Retinopathy of Prematurity; Role; Signal Transduction; Solutions; Stress; Technology; Testing; Therapeutic; Vascular Diseases; Vascular Endothelial Growth Factors; Vascular Endothelium; angiogenesis; in vivo; mouse model; neovascularization; ocular angiogenesis; response; retinal angiogenesis; small molecule; therapeutic target; transcription factor

DESCRIPTION (provided by applicant): This project focuses on microRNA mechanisms on ocular angiogenesis. Angiogenesis plays a central role in eye development and also many major blinding retinal diseases, such as age related macular degeneration (AMD).The discovery of MicroRNAs as small endogenous RNAs regulating gene expression post-transcriptionally has revolutionized our understanding of genetic pathway networks, and ignited tremendous studies to explore microRNA therapeutics for numerous diseases. Our broad long-term goals are: (a) to understand the mechanisms of how specific microRNAs regulate ocular vascular development and (b) to decipher the roles of these microRNAs in vascular retinopathies. Our recent studies show that a specific microRNA, miR-126, is an endothelial cell specific microRNA regulating angiogenic pathways in response to vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF). We also have preliminary data that miR-126 is expressed specifically in the endothelium in the retina/choroid, and is required for sprouting retinal angiogenesis. Our organizing hypothesis for this proposal is that by regulating multiple angiogenic pathways miR-126 plays a critical regulatory role in ocular angiogenesis and in the pathogenesis of neovascular AMD. As a small molecule with multiple regulatory functions, miR-126 would be an attractive therapeutic target for blinding vascular retinopathies. Specific Aim I is to define the expression pattern and regulation mechanism of miR-126 in the retina/choroid. Specific Aim II is to identify the requirement and mechanism whereby miR-126 regulates retinal vascular development. Specific Aim III is to determine the mechanism by which miR-126 regulates neovascularization in a laser induced choroidal neovascularization model.

描述（由申请人提供）：该项目重点研究眼部血管生成的 microRNA 机制。血管生成在眼睛发育以及许多主要致盲性视网膜疾病中发挥着核心作用，例如年龄相关性黄斑变性 (AMD)。MicroRNA 作为转录后调节基因表达的小内源性 RNA 的发现彻底改变了我们对遗传通路网络的理解，并且引发了大量研究来探索 microRNA 治疗多种疾病的方法。我们广泛的长期目标是：(a) 了解特定 microRNA 如何调节眼部血管发育的机制，以及 (b) 破译这些 microRNA 在血管性视网膜病变中的作用。我们最近的研究表明，一种特定的 microRNA，miR-126，是一种内皮细胞特异性的 microRNA，可响应血管内皮生长因子（VEGF）和成纤维细胞生长因子（FGF）调节血管生成途径。我们还有初步数据表明 miR-126 在视网膜/脉络膜的内皮细胞中特异性表达，并且是视网膜血管生成所必需的。我们对此提议的组织假设是，通过调节多种血管生成途径，miR-126 在眼部血管生成和新生血管性 AMD 的发病机制中发挥着关键的调节作用。作为一种具有多种调节功能的小分子，miR-126 将成为致盲性血管性视网膜病的一个有吸引力的治疗靶点。具体目的一是明确miR-126在视网膜/脉络膜中的表达模式和调控机制。具体目标 II 是确定 miR-126 调节视网膜血管发育的要求和机制。具体目标 III 是确定 miR-126 在激光诱导脉络膜新生血管形成模型中调节新生血管形成的机制。